BioNTech wants “to help eradicate malaria” by using the same breakthrough mRNA technology it used to develop its coronavirus vaccine, the pharmaceutical company said on Monday. The Germany-based group said it aimed to begin clinical malaria vaccine trials by the end of 2022. If successful, the shot could be a major development in the fight against malaria, which kills more than 400,000 people a year — mainly young children in Africa. The disease is caused by a parasite that commonly infects a certain type of mosquito which feeds on humans. “We will do whatever it takes to develop a safe and effective mRNA-based malaria vaccine that will prevent the disease, reduce mortality and ensure a sustainable solution for the African continent and other regions affected by this disease,” BioNTech CEO Ugur Sahin said in a statement. Scientists believe mRNA technology, which prompts an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against several diseases. Using this technology is also a faster way of developing a vaccine than traditional methods and could bring an end to the decades-long search for a reliable malaria shot.
SOURCE: DEUTSCHE WELLE
More Stories
Re-entry of Higher Capacity Aircraft on African Routes Shows Recovery of Hard Hit Travel Sector
For the First Time, Jumia May have to Worry about its Liquidity Position
The Pros and Cons of South Africa’s Tourism Marketing Strategy
Can Southern African States Move Further Up the Lithium Value Chain?
Dutch Energy Producer Eyes Africa Expansion
Libya’s Oil Ministry has Rejected the $8bn Offshore Gas Projects Deal
Zimbabwe’s Leader is Seeking Investment for a New National Capital
South African Poultry Farmers in Dire Straits
Travel Marketplace for Immersive Experiences Matching Tourists with Verified African Curators
Africa’s Only All-Female Solar Panel Assembly Plant Launched in Cape Town
Pope Francis Condemns “Economic Colonialism” as He Arrives in the DRC
Encouraging Signs that Corruption is being Successfully Tackled in Parts of Africa